Global BGMS (Blood Glucose Monitoring System) Market Size By Type (Blood Glucose meters, Testing strips), By Application (Type 2 Diabetes, Type 1 Diabetes), By Region, And Segment Forecasts, 2023 to 2...

lobal BGMS (Blood Glucose Monitoring System) Market Report Description

The Global Blood Glucose Monitoring System (BGMS) Market was valued at USD 16.4 billion in 2023 and is projected to reach USD 29.1 billion by 2031, growing at a CAGR of 7.5% during the forecast period from 2023 to 2031. The market growth is driven by the rising global prevalence of diabetes, growing health awareness, technological advancements in continuous glucose monitoring systems, and increasing adoption of digital health platforms. The demand for minimally invasive and real-time monitoring solutions is further enhancing market penetration, especially in developed economies and emerging markets with growing diabetic populations.

Drivers:

1. Increasing Prevalence of Diabetes:

The global surge in diabetes cases, particularly type 2 diabetes, is significantly fueling the demand for efficient and user-friendly blood glucose monitoring solutions.

2. Rise in Geriatric Population and Lifestyle Diseases:

Age-related susceptibility to diabetes and sedentary lifestyles are amplifying the need for regular glucose monitoring, driving the market for both SMBG and CGM systems.

3. Technological Advancements in CGMs and Smart Devices:

Integration with mobile apps, AI-driven analytics, and wearable technologies has transformed user experience, offering real-time alerts and insights for better glycemic control.

Restraints:

1. High Cost of Continuous Glucose Monitoring Devices:

Despite the growing adoption, the higher cost of CGM devices compared to traditional glucose meters can limit access in low-income regions.

2. Reimbursement Challenges in Developing Economies:

Lack of comprehensive insurance coverage and low healthcare spending in several developing countries pose hurdles for widespread BGMS adoption.

Opportunity:

1. Expansion in Emerging Markets:

Rapid urbanization, increased healthcare infrastructure investment, and rising health consciousness in Asia-Pacific and Latin America provide lucrative growth avenues.

2. Growth in Home Healthcare and Remote Monitoring:

The shift towards self-monitoring and remote care—especially post-COVID-19—offers tremendous potential for market expansion and innovation in telehealth-compatible BGMS.

Market by System Type Insights:

The Continuous Glucose Monitoring (CGM) segment dominated the market in 2023, accounting for the largest revenue share. This segment is projected to maintain its lead due to the increasing preference for real-time monitoring, reduced need for finger pricks, and better long-term glycemic control.

Meanwhile, the Self-Monitoring Blood Glucose (SMBG) segment continues to see steady demand, particularly among patients with cost sensitivity and those with type 2 diabetes not on intensive insulin therapy.

Market by End-use Insights:

Based on end-use, Hospitals & Clinics led the market in 2023 owing to the demand for accurate monitoring and professional diagnosis. However, the Home Care segment is expected to witness the fastest growth rate due to increased emphasis on personal health management and the convenience of at-home monitoring.

Market by Regional Insights:

North America was the largest regional market in 2023, supported by advanced healthcare infrastructure, high diabetes prevalence, and strong reimbursement policies. However, Asia-Pacific is projected to register the highest CAGR during the forecast period, driven by a rising diabetic population, increased health awareness, and expanding access to modern diagnostics in countries such as India and China.

Competitive Scenario:

Major players in the BGMS market include Abbott Laboratories, Dexcom, Inc., Medtronic plc, F. Hoffmann-La Roche Ltd, Ascensia Diabetes Care Holdings AG, LifeScan, Inc., Senseonics Holdings, Inc., ACON Laboratories, and i-SENS, Inc. Companies are focusing on R&D, strategic partnerships, and regional expansions to enhance their product portfolios and technological capabilities.

Scope of Work – Global BGMS (Blood Glucose Monitoring System) Market

Report Metric Details

Market Size (2023) USD 16.4 billion

Projected Market Size (2031) USD 29.1 billion

CAGR (2023-2031) 7.5%

Market Segments By System Type (CGM, SMBG), By End-use (Hospitals & Clinics, Home Care), By Region

Growth Drivers Rising diabetes prevalence, technological innovations, aging population

Opportunities Emerging market expansion, rise in telemedicine and home healthcare solutions

Key Market Developments:

March 2023: Abbott Laboratories launched its next-gen FreeStyle Libre 4 system with advanced real-time alerts and longer wear time.

June 2024: Dexcom received FDA approval for G8 CGM, integrating with wearable insulin pumps for closed-loop therapy.

January 2025: Medtronic announced a partnership with a digital health startup to enhance AI-powered insights for its Guardian CGM systems.

FAQs

1) What is the current market size of the Global BGMS (Blood Glucose Monitoring System) Market?

The market was valued at USD 16.4 billion in 2023.

2) What is the major growth driver of the Global BGMS (Blood Glucose Monitoring System) Market?

The primary growth driver is the increasing global prevalence of diabetes and the demand for real-time, user-friendly monitoring solutions.

3) Which is the largest region during the forecast period in the Global BGMS (Blood Glucose Monitoring System) Market?

North America holds the largest market share, driven by advanced healthcare systems and high adoption of CGM technologies.

4) Which segment accounted for the largest market share in the Global BGMS (Blood Glucose Monitoring System) Market?

The Continuous Glucose Monitoring (CGM) segment accounted for the largest share in 2023.

5) Who are the key market players in the Global BGMS (Blood Glucose Monitoring System) Market?

Key players include Abbott Laboratories, Dexcom, Medtronic, Roche, Ascensia Diabetes Care, and others.

Would you like this exported to a Word or PDF format as well?